Open original FDA record ↗Recall record
- FDA identifier
- Z-0282-2021
- Company in FDA record
- Fujifilm Medical Systems U.S.A., Inc.
- FDA record creation date
- Oct 22, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
FUJIFILM has become aware of the possibility that certain CT studies may report a much higher 3D Sphere MAX value than expected. This issue is specific to 3D Sphere - other density tools are not affected.
Source facts
- Action
- Letter was sent to all affected customers on 09/11/2020 stating the following: FUJIFILM will offer an upgrade to Synapse PACS 7.1.100 to resolve this issue. Synapse PACS 7.1.100 is estimated to be available by the end of September. Until the patch is available, users can continue to safely use Synapse PACS by following these additional instructions: 1. Ensure that the 3D Sphere MAX value is within the spheres range. If the 3D Sphere MAX value is observed to be much higher than expected, the value should not be used when rendering a clinical decision until the issue is corrected. Customers should complete and return the Field Action Verification Form attached to the recall letter.
- Initiated
- 2020-09-11
- Root cause
- Software change control
- Terminated
- 2021-11-17
- Distribution
- US Nationwide distribution including in the state of Minnesota.
- Recall number
- Z-0282-2021
- Recall status
- Terminated
- CDRH record ID
- 183827
- FDA record created
- 2020-10-22
- Recall event number
- 86494